Related Experiment Video

Updated: Aug 7, 2026

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays
13:22

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

Raf kinase inhibitor protein is downregulated in hepatocellular carcinoma

Marion M Schuierer1, Frauke Bataille, Thomas S Weiss

  • 1Institute of Pathology, University of Regensburg, 93053 Regensburg, Germany.

Oncology Reports
|July 26, 2006
PubMed

Insights

Raf-1 kinase inhibitory protein (RKIP) is downregulated in hepatocellular carcinoma (HCC), impacting cell proliferation and tumour progression. Reduced RKIP levels correlate with increased ERK activity, suggesting RKIP

Area of Science:

  • Molecular Biology
  • Oncology
  • Hepatology

Background:

  • The Ras/Raf/MEK/ERK pathway is crucial for cell proliferation and transformation, frequently deregulated in cancers.
  • Elevated ERK levels are observed in hepatocellular carcinoma (HCC) and linked to tumor progression, but mechanisms remain unclear.
  • Raf-1 kinase inhibitory protein (RKIP) is a key regulator of this pathway.

Purpose of the Study:

  • To investigate the role of RKIP expression and its functional relevance in hepatocellular carcinoma (HCC).
  • To analyze RKIP expression patterns in HCC tissues and cirrhotic liver tissues.

Main Methods:

  • Analysis of RKIP mRNA and protein expression in HCC cell lines and tissues using quantitative real-time PCR and Western blotting.
  • Functional studies involving transfection of HCC cells with RKIP expression constructs and antisense RKIP constructs.
  • Immunohistochemical analysis of RKIP expression in non-cancerous cirrhotic liver tissues.

Main Results:

  • RKIP mRNA and protein expression were significantly downregulated in HCC cell lines and tissues compared to normal liver samples.
  • Overexpression of RKIP in HCC cells inhibited the Raf/MEK/ERK pathway, decreasing ERK1/2 and AP-1 activity.
  • Downregulation of RKIP led to increased ERK1/2 and AP-1 activity.
  • Immunohistochemistry revealed altered RKIP membrane localization in cirrhotic liver tissues compared to normal cytoplasmic distribution.

Conclusions:

  • Downregulation of RKIP is functionally relevant in HCC development and progression.
  • Altered RKIP expression in cirrhosis may contribute to malignant transformation of hepatocytes.
  • RKIP represents a potential therapeutic target in HCC.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...